Xu F - Search Results

1

Integrated proteogenomic characterization of urothelial carcinoma of the bladder.

Xu N, Yao Z, Shang G, Ye D, Wang H, Zhang H, Qu Y, Xu F, Wang Y, Qin Z, Zhu J, Zhang F, Feng J, Tian S, Liu Y, Zhao J, Hou J, Guo J, Hou Y, Ding C. Xu N, et al. Among authors: xu f. J Hematol Oncol. 2022 Jun 3;15(1):76. doi: 10.1186/s13045-022-01291-7. J Hematol Oncol. 2022. PMID: 35659036 Free PMC article.

2

The Oncogenic Role of COL23A1 in Clear Cell Renal Cell Carcinoma.

Xu F, Chang K, Ma J, Qu Y, Xie H, Dai B, Gan H, Zhang H, Shi G, Zhu Y, Zhu Y, Shen Y, Ye D. Xu F, et al. Sci Rep. 2017 Aug 29;7(1):9846. doi: 10.1038/s41598-017-10134-2. Sci Rep. 2017. PMID: 28852123 Free PMC article.

3

Author Correction: The Oncogenic Role of COL23A1 in Clear Cell Renal Cell Carcinoma.

Xu F, Chang K, Ma J, Qu Y, Xie H, Dai B, Gan H, Zhang H, Shi G, Zhu Y, Zhu Y, Shen Y, Ye D. Xu F, et al. Sci Rep. 2018 Apr 12;8(1):6001. doi: 10.1038/s41598-018-23756-x. Sci Rep. 2018. PMID: 29651135 Free PMC article.

4

SPOP promotes ATF2 ubiquitination and degradation to suppress prostate cancer progression.

Ma J, Chang K, Peng J, Shi Q, Gan H, Gao K, Feng K, Xu F, Zhang H, Dai B, Zhu Y, Shi G, Shen Y, Zhu Y, Qin X, Li Y, Zhang P, Ye D, Wang C. Ma J, et al. Among authors: xu f. J Exp Clin Cancer Res. 2018 Jul 11;37(1):145. doi: 10.1186/s13046-018-0809-0. J Exp Clin Cancer Res. 2018. PMID: 29996942 Free PMC article.

5

High expression of F2RL3 correlates with aggressive features and poor survival in clear cell renal cell carcinoma.

Cao D, Qu Y, Zhang X, Xu F, Zhou S, Zhang G, Dai B, Zhu Y, Shi G, Shen Y, Zhu Y, Zhang H, Ye D, Zhao J. Cao D, et al. Among authors: xu f. J Cancer. 2018 Sep 8;9(18):3400-3406. doi: 10.7150/jca.23923. eCollection 2018. J Cancer. 2018. PMID: 30271502 Free PMC article.

6

APC/C^CDH1 synchronizes ribose-5-phosphate levels and DNA synthesis to cell cycle progression.

Li Y, Yao CF, Xu FJ, Qu YY, Li JT, Lin Y, Cao ZL, Lin PC, Xu W, Zhao SM, Zhao JY. Li Y, et al. Nat Commun. 2019 Jun 7;10(1):2502. doi: 10.1038/s41467-019-10375-x. Nat Commun. 2019. PMID: 31175280 Free PMC article.

7

Inactivation of the AMPK-GATA3-ECHS1 Pathway Induces Fatty Acid Synthesis That Promotes Clear Cell Renal Cell Carcinoma Growth.

Qu YY, Zhao R, Zhang HL, Zhou Q, Xu FJ, Zhang X, Xu WH, Shao N, Zhou SX, Dai B, Zhu Y, Shi GH, Shen YJ, Zhu YP, Han CT, Chang K, Lin Y, Zang WD, Xu W, Ye DW, Zhao SM, Zhao JY. Qu YY, et al. Cancer Res. 2020 Jan 15;80(2):319-333. doi: 10.1158/0008-5472.CAN-19-1023. Epub 2019 Nov 5. Cancer Res. 2020. PMID: 31690668

8

The Prognostic Value of Programmed Death-Ligand 1 in a Chinese Cohort With Clear Cell Renal Cell Carcinoma.

Xiao WJ, Xu FJ, Zhang X, Zhou SX, Zhang HL, Dai B, Zhu Y, Shi GH, Shen YJ, Zhu YP, Qu YY, Zhao JY, Ye DW. Xiao WJ, et al. Front Oncol. 2019 Nov 25;9:879. doi: 10.3389/fonc.2019.00879. eCollection 2019. Front Oncol. 2019. PMID: 31824835 Free PMC article.

9

Identification of prognostic biomarkers in papillary renal cell carcinoma and PTTG1 may serve as a biomarker for predicting immunotherapy response.

Tian X, Xu WH, Xu FJ, Li H, Anwaier A, Wang HK, Wan FN, Zhu Y, Cao DL, Zhu YP, Shi GH, Qu YY, Zhang HL, Ye DW. Tian X, et al. Ann Med. 2022 Dec;54(1):211-226. doi: 10.1080/07853890.2021.2011956. Ann Med. 2022. PMID: 35037540 Free PMC article.

10

A proteogenomic analysis of clear cell renal cell carcinoma in a Chinese population.

Qu Y, Feng J, Wu X, Bai L, Xu W, Zhu L, Liu Y, Xu F, Zhang X, Yang G, Lv J, Chen X, Shi GH, Wang HK, Cao DL, Xiang H, Li L, Tan S, Gan HL, Sun MH, Qiu J, Zhang H, Zhao JY, Ye D, Ding C. Qu Y, et al. Among authors: xu f, xu w. Nat Commun. 2022 Apr 19;13(1):2052. doi: 10.1038/s41467-022-29577-x. Nat Commun. 2022. PMID: 35440542 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

14,016 results

Search Page